Introduction The survival of patients with lung cancer in the last decade has had an increasing trend if data from all over the world is compared.
← all excerpts
The efficacy outcomes in non-small cell lung cancer patients treated with PD axis inhibitor agents - a population-based study of the Vojvodina region.
1
—
—